Impact of lymph node metastasis in differentiated carcinoma of the thyroid: A matched-pair analysis

Head and Neck

Volumn 18, Issue 2, 1996, Pages 127-132

  Hughes, Christopher J ^a   Shaha, Ashok R ^a   Shah, Jatin P ^a   Loree, Thom R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; THYROID CARCINOMA; TUMOR DIFFERENTIATION;

EID: 0029865664     PISSN: 01486403     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0347(199603/04)18:2<127::aid-hed3>3.0.co;2-3     Document Type: Article

References (50)

1. Hirabayashi RN, Lindsay S. Carcinoma of the thyroid gland: a statistical study of 390 patients. J Clin Endocrinol Metab 1961;21:1596-1610.
2. Russel MA, Gilbert EF, Jaeschke WF. Prognostic features of thyroid cancer. Cancer 1975;36:553-559.
3. Franssila KO. Prognosis in thyroid carcinoma. Cancer 1975;36:1138-1146.
4. Cady B, Sedgwick CE, Meissner WA, et al. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid cancer. Ann Surg 1976;184:541-553.
5. Cady B, Sedgwick CE, Meissner WA, et al. Risk factor analysis in differentiated thyroid cancer. Cancer 1979;43:810-820.
6. Samaan NA, Maheshwari YK, Nader CS, et al. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 1983;56:1131-1138.
7. McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Proc 1986;61:978-996.
8. Rossi RL, Cady B, Silverman ML, et al. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg 1986;10:612-622.
9. Mazzaferri EL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Sem Oncol 1987;14:315-332.
10. Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma. A study of the EORTC thyroid cancer co-operative group. Eur J Cancer 1979;15:1033-1041.
11. Wanebo HJ, Andrews W, Kaiser DL. Thyroid cancer: some basic considerations. Am J Surg 1982;142:474-479.
12. Fourquet A, Asselain B, Joly J. Cancer de la thyroide. Analyse multi-dimensionalles des facteurs prognostiques. Ann Endocrinol 1983;44:121-126.
13. Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794-804.
14. Tennval J, Biorkland A, Moller T, et al. Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Cancer 1986;57:1405-1414.
15. Bacourt F, Asselain B, Savoie JC, et al. Multifactorial study of prognostic factors in differentiated thyroid carcinoma and a re-evaluation of the importance of age. Br J Surg 1986;73;274-277.
16. Simpson WJ, MCKinney SE, Carruthers JS, et al. Papillary and follicular cancer. Prognostic factors in 1578 patients. Am J Med 1987;83:479-488.
17. Cunningham MP, Duda RB, Recant W, et al. Survival discriminants for differentiated thyroid cancer. Am J Surg 1990;160:344-347.
18. Hay ID. Papillary Thyroid Carcinoma. Endocrinol Metab Clin N Am 1990;19:545-576.
19. Schindler AM, van Melle G, Evequoz B, Scaziga B. Prognostic factors in papillary carcinoma of the thyroid. Cancer 1991;68:324-330.
20. Shah JP, Loree TP, Dharker D, et al. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992;164:658-661.
21. Beenken S, Guillamondegui O, Shallenberger R, et al. Prognostic factors in patients dying of well-differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 1989;115:326-330.
22. McHenry CR, Rosen IB, Walfish PG. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 1991;162:353-356.
23. Coburn MC, Wanebo HJ. Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg 1992;164:671-676.
24. Attie JN, Setzin M, Klein L. Thyroid carcinoma presenting as an enlarged cervical lymph node. Am J Surg 1993;166:428-430.
25. American Joint Council against Cancer, Manual for TNM Staging.
26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:475-481.
27. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977;35:1-39.
28. Zar. Biostatistical analysis. Englewood Cliffs, NJ: Prentice Hall, 1974:291-295.
29. Harwood J, Clark OH, Dunphy JE. Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg 1978;136:107-112.
30. Sellers M, Beenken S, Blankenship A. Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg 1992;164:578-581.
31. Kocher T. Zur klinischen Beurteilung der bosartigen Geschwulste der Schilddruse. Deutsche Zeitschr Chir 1907;91:197-307.
32. Wilson LB. Malignant tumors of the thyroid. Ann Surg 1921;24:129.
33. Trotter W. Carcinoma of thyroid, with extensive involvement of lymphatic glands; operation three and a half years ago; no recurrence. Proc Roy Soc Med 1910-11; IV, Clin. Sect. 118.
34. Duncan JA, Cantril ST, Lund PK. The bizarre behaviour of thyroid cancer. West J Surg 1952;60:435-447.
35. Martin H. The surgery of thyroid tumors. Cancer 1954;7:1063-1099.
36. Crile G Jr. Treatment of papillary carcinoma of the thyroid with lateral cervical metastases. Am J Surg 1950;80:419-423.
37. Crile G Jr, Hazard JB. Relationship of the age of the patient to the natural history and prognosis of carcinoma of the thyroid. Ann Surg 1953;138:33-38.
38. Graver LF. Cancer of the thyroid and its present-day treatment. Ann Surg 1925;82:833-853.
39. Exelby PR, Prazell EL. Carcinoma of the thyroid in children. Surg Clin N Am 1979;49:249-259.
40. Buckwalter JA, Gurll NJ, Thomas CG Jr. Cancer of the thyroid in youth. World J Surg 1981;5:15-25.
41. Rossi RL, Nieroda C, Cady B, Wool MS. Malignancies of the thyroid gland. The Lahey Clinic experience. Surg Clin N Am 1985;65:211-230.
42. Russell WO, Ibanez ML, Clark RL, White EC. Thyroid carcinoma. Classification, intraglandular dissemination, and clinicopathological study based upon whole organ sections of 80 glands. Cancer 1963;11:1425-1460.
43. Katoh R, Sasaki J, Kurihara H, et al. Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients. Cancer 1991;70:1585-1590.
44. Tollefsen HR, Shah JP, Huvos AG. Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical treatment. Am J Surg 1972;124:468-472.
45. Buckwalter JA, Thomas CG. Selection of surgical treatment for well differentiated thyroid carcinomas. Ann Surg 1972;176:565-578.
46. Shah JP. Differentiated thyroid cancer. In Bloom HJG, Hanham IWF, Shaw HJ, eds. Head and neck oncology. New York: Ravens Press, 1986:207-214.
47. Attie JN, Khafif RA, Steckler RM. Elective neck dissection in papillary carcinoma of the thyroid. Am J Surg 1971;122:464-471.
48. Pemberton J de J. Malignant lesions of thyroid gland; a review of 774 cases. Surg Gyn Obs 1939;69:417.
49. Ruegemer JJ, Hay ID, Bergstralh EJ, et al. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988;67:501-508.
50. Shah JP, Loree TR, Dharker D, Strong EW. Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. Am J Surg 1993;166:331-335.